HUM logo

Humana (HUM) EBITDA

annual EBITDA:

$3.35B-$1.44B(-30.13%)
December 31, 2024

Summary

  • As of today (May 29, 2025), HUM annual EBITDA is $3.35 billion, with the most recent change of -$1.44 billion (-30.13%) on December 31, 2024.
  • During the last 3 years, HUM annual EBITDA has fallen by -$1.04 billion (-23.77%).
  • HUM annual EBITDA is now -39.10% below its all-time high of $5.50 billion, reached on December 31, 2020.

Performance

1-year change

-30.13%

3-year change

-23.77%

5-year change

-21.62%

15-year change

-29.45%

HUM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.24%
HUM annual EBITDA is higher than 97.24% of companies in Healthcare sector

Range

All-time high

$5.50B
HUM annual EBITDA is currently -39.10% below its historical high of $5.50 billion

3-year low

$3.35B
HUM annual EBITDA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
HUM previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
HUM next annual earnings announcement has not yet been scheduled

OtherHUMincome statement metrics

Annual revenue

$117.76B
HUM annual revenue is $117.76 billion

annual net income

$1.21B
HUM annual net profit is $1.21 billion

annual EBIT

$2.38B
HUM annual earnings before interest & taxes is $2.38 billion

Annual EPS

$9.98
HUM annual earnings per share is $9.98

quarterly EBITDA:

$2.07B+$2.52B(+551.09%)
March 31, 2025

Summary

  • As of today (May 29, 2025), HUM quarterly EBITDA is $2.07 billion, with the most recent change of +$2.52 billion (+551.09%) on March 31, 2025.
  • Over the past year, HUM quarterly EBITDA has increased by +$651.00 million (+46.01%).
  • HUM quarterly EBITDA is now -26.53% below its all-time high of $2.81 billion, reached on June 30, 2020.

Performance

3-month change

+551.09%

1-year change

+46.01%

3-year change

+36.37%

5-year change

+124.08%

HUM quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.2%
HUM quarterly EBITDA is higher than 98.2% of companies in Healthcare sector

Range

All-time high

$2.81B
HUM quarterly EBITDA is currently -26.53% below its historical high of $2.81 billion

3-year low

-$458.00M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
HUM previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
HUM next earnings announcement is scheduled for Jul 30, 2025

OtherHUMincome statement metrics

Quarterly revenue

$32.11B
HUM quarterly revenue is $32.11 billion

quarterly net income

$1.24B
HUM quarterly net profit is $1.24 billion

quarterly EBIT

$1.85B
HUM quarterly earnings before interest & taxes is $1.85 billion

Quarterly EPS

$10.30
HUM quarterly earnings per share is $10.30

TTM EBITDA:

$4.00B+$651.00M(+19.44%)
March 31, 2025

Summary

  • As of today (May 29, 2025), HUM TTM EBITDA is $4.00 billion, with the most recent change of +$651.00 million (+19.44%) on March 31, 2025.
  • Over the past year, HUM TTM EBITDA has dropped by -$263.00 million (-6.17%).
  • HUM TTM EBITDA is now -38.61% below its all-time high of $6.52 billion, reached on September 30, 2020.

Performance

3-month change

+19.44%

1-year change

-6.17%

3-year change

-13.64%

5-year change

-5.9%

HUM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.43%
HUM TTM EBITDA is higher than 97.43% of companies in Healthcare sector

Range

All-time high

$6.52B
HUM TTM EBITDA is currently -38.61% below its historical high of $6.52 billion

3-year low

$3.35B
HUM TTM EBITDA is currently +19.44% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
HUM previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
HUM next earnings announcement is scheduled for Jul 30, 2025

OtherHUMincome statement metrics

TTM revenue

$120.26B
HUM TTM revenue is $120.26 billion

TTM net income

$1.71B
HUM TTM net profit is $1.71 billion

TTM EBIT

$3.06B
HUM TTM earnings before interest & taxes is $3.06 billion

TTM EPS

$14.14
HUM TTM earnings per share is $14.14

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$3.35B
HUM annual EBITDA is $3.35 billion

annual net income

$1.21B
HUM annual net profit is $1.21 billion

annual interest expense

$660.00M
HUM annual interest expense is $660.00 million

annual income tax

$413.00M
HUM annual income tax is $413.00 million

annual D&A

$968.00M
HUM annual depreciation & amortization is $968.00 million

HUM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.1%+46.0%-6.2%
3 y3 years-23.8%+36.4%-13.6%
5 y5 years-21.6%+124.1%-5.9%

HUM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-30.4%at lowat high+551.1%-26.2%+19.4%
5 y5-year-39.1%at low-26.5%+551.1%-38.6%+19.4%
alltimeall time-39.1%+1469.8%-26.5%+551.1%-38.6%+8510.7%

HUM EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.07B(-551.1%)
$4.00B(+19.4%)
Dec 2024
$3.35B(-30.1%)
-$458.00M(-143.1%)
$3.35B(-7.0%)
Sep 2024
-
$1.06B(-20.0%)
$3.60B(-9.6%)
Jun 2024
-
$1.33B(-6.1%)
$3.98B(-6.5%)
Mar 2024
-
$1.42B(-783.6%)
$4.26B(-11.1%)
Dec 2023
$4.79B(-0.4%)
-$207.00M(-114.3%)
$4.79B(-8.8%)
Sep 2023
-
$1.45B(-10.0%)
$5.25B(-3.1%)
Jun 2023
-
$1.61B(-17.3%)
$5.42B(+3.4%)
Mar 2023
-
$1.95B(+665.7%)
$5.24B(+8.9%)
Dec 2022
$4.81B(+9.6%)
$254.00M(-84.3%)
$4.81B(+0.6%)
Sep 2022
-
$1.61B(+12.6%)
$4.79B(-5.8%)
Jun 2022
-
$1.43B(-5.5%)
$5.08B(+9.6%)
Mar 2022
-
$1.51B(+573.3%)
$4.63B(+5.4%)
Dec 2021
$4.39B(-20.1%)
$225.00M(-88.2%)
$4.39B(+11.4%)
Sep 2021
-
$1.91B(+93.0%)
$3.94B(-2.1%)
Jun 2021
-
$987.00M(-22.6%)
$4.03B(-31.2%)
Mar 2021
-
$1.28B(-664.6%)
$5.85B(+6.4%)
Dec 2020
$5.50B(+28.7%)
-$226.00M(-111.4%)
$5.50B(-15.6%)
Sep 2020
-
$1.99B(-29.2%)
$6.52B(+15.7%)
Jun 2020
-
$2.81B(+205.0%)
$5.63B(+32.5%)
Mar 2020
-
$922.00M(+16.6%)
$4.25B(-0.5%)
Dec 2019
$4.27B(+51.8%)
$791.00M(-28.7%)
$4.27B(+3.9%)
Sep 2019
-
$1.11B(-22.4%)
$4.11B(+0.6%)
Jun 2019
-
$1.43B(+51.4%)
$4.09B(+42.9%)
Mar 2019
-
$944.00M(+50.1%)
$2.86B(+1.6%)
Dec 2018
$2.81B(-40.7%)
$629.00M(-42.0%)
$2.81B(-2.3%)
Sep 2018
-
$1.08B(+437.1%)
$2.88B(+3.9%)
Jun 2018
-
$202.00M(-77.5%)
$2.77B(-26.8%)
Mar 2018
-
$899.00M(+29.5%)
$3.79B(-20.2%)
Dec 2017
$4.75B(+115.2%)
$694.00M(-29.0%)
$4.75B(+27.2%)
Sep 2017
-
$978.00M(-19.8%)
$3.73B(-2.3%)
Jun 2017
-
$1.22B(-34.3%)
$3.82B(+12.4%)
Mar 2017
-
$1.86B(-678.2%)
$3.40B(+54.1%)
Dec 2016
$2.21B(-28.0%)
-$321.00M(-130.1%)
$2.21B(-24.7%)
Sep 2016
-
$1.07B(+33.4%)
$2.93B(+9.9%)
Jun 2016
-
$799.00M(+20.7%)
$2.67B(-5.5%)
Mar 2016
-
$662.00M(+63.9%)
$2.82B(-7.9%)
Dec 2015
$3.06B(+9.0%)
$404.00M(-49.6%)
$3.06B(-2.9%)
Sep 2015
-
$802.00M(-15.9%)
$3.15B(+3.3%)
Jun 2015
-
$954.00M(+5.5%)
$3.05B(+5.8%)
Mar 2015
-
$904.00M(+82.6%)
$2.89B(+2.7%)
Dec 2014
$2.81B(+13.0%)
$495.00M(-29.4%)
$2.81B(+16.3%)
Sep 2014
-
$701.00M(-10.9%)
$2.42B(-1.1%)
Jun 2014
-
$787.00M(-5.0%)
$2.44B(-0.2%)
Mar 2014
-
$828.00M(+728.0%)
$2.45B(-1.6%)
Dec 2013
$2.49B(+5.6%)
$100.00M(-86.2%)
$2.49B(-11.1%)
Sep 2013
-
$727.00M(-8.3%)
$2.80B(-1.8%)
Jun 2013
-
$793.00M(-8.5%)
$2.85B(+4.4%)
Mar 2013
-
$867.00M(+112.0%)
$2.73B(+15.8%)
Dec 2012
$2.35B(-11.1%)
$409.00M(-47.5%)
$2.35B(-0.4%)
Sep 2012
-
$779.00M(+15.9%)
$2.36B(-0.9%)
Jun 2012
-
$672.00M(+36.0%)
$2.38B(-6.2%)
Mar 2012
-
$494.00M(+18.2%)
$2.54B(-4.0%)
Dec 2011
$2.65B(+25.0%)
$418.00M(-47.8%)
$2.65B(+6.1%)
Sep 2011
-
$800.00M(-3.5%)
$2.50B(+3.6%)
Jun 2011
-
$829.00M(+38.2%)
$2.41B(+8.9%)
Mar 2011
-
$600.00M(+125.0%)
$2.21B(+4.4%)
Dec 2010
$2.12B(+8.1%)
$266.65M(-62.6%)
$2.12B(-9.7%)
Sep 2010
-
$712.99M(+12.9%)
$2.34B(+7.1%)
Jun 2010
-
$631.37M(+24.8%)
$2.19B(+5.0%)
Mar 2010
-
$506.00M(+2.3%)
$2.09B(+6.5%)
Dec 2009
$1.96B
$494.63M(-11.3%)
$1.96B(+8.1%)
Sep 2009
-
$557.70M(+5.8%)
$1.81B(+12.4%)
Jun 2009
-
$527.00M(+39.2%)
$1.61B(+8.8%)
DateAnnualQuarterlyTTM
Mar 2009
-
$378.55M(+8.9%)
$1.48B(+14.5%)
Dec 2008
$1.29B(-16.2%)
$347.59M(-3.0%)
$1.29B(-5.7%)
Sep 2008
-
$358.33M(-9.6%)
$1.37B(-11.5%)
Jun 2008
-
$396.34M(+107.3%)
$1.55B(-0.9%)
Mar 2008
-
$191.22M(-55.1%)
$1.56B(+1.4%)
Dec 2007
$1.54B(+58.4%)
$426.17M(-20.6%)
$1.54B(+9.2%)
Sep 2007
-
$536.70M(+30.9%)
$1.41B(+19.7%)
Jun 2007
-
$409.92M(+140.8%)
$1.18B(+22.4%)
Mar 2007
-
$170.20M(-42.6%)
$964.47M(-1.0%)
Dec 2006
$973.82M(+65.1%)
$296.41M(-2.5%)
$973.82M(+16.6%)
Sep 2006
-
$304.06M(+56.9%)
$834.98M(+30.1%)
Jun 2006
-
$193.81M(+7.9%)
$641.86M(+4.4%)
Mar 2006
-
$179.55M(+14.0%)
$614.99M(+4.3%)
Dec 2005
$589.89M(+5.9%)
$157.56M(+42.0%)
$589.89M(+10.2%)
Sep 2005
-
$110.94M(-33.5%)
$535.30M(-9.2%)
Jun 2005
-
$166.93M(+8.1%)
$589.55M(+2.1%)
Mar 2005
-
$154.45M(+50.0%)
$577.46M(+3.7%)
Dec 2004
$556.81M(+15.9%)
$102.98M(-37.7%)
$556.81M(-3.4%)
Sep 2004
-
$165.19M(+6.7%)
$576.49M(+7.4%)
Jun 2004
-
$154.84M(+15.7%)
$536.56M(+3.6%)
Mar 2004
-
$133.80M(+9.1%)
$518.16M(+7.9%)
Dec 2003
$480.36M(+40.6%)
$122.65M(-2.1%)
$480.36M(+25.3%)
Sep 2003
-
$125.26M(-8.2%)
$383.35M(+3.7%)
Jun 2003
-
$136.44M(+42.1%)
$369.68M(+10.5%)
Mar 2003
-
$96.00M(+274.4%)
$334.55M(-2.0%)
Dec 2002
$341.53M(-10.0%)
$25.64M(-77.0%)
$341.53M(-20.3%)
Sep 2002
-
$111.59M(+10.1%)
$428.29M(+4.2%)
Jun 2002
-
$101.32M(-1.6%)
$411.00M(+15.6%)
Mar 2002
-
$102.98M(-8.4%)
$355.45M(+18.9%)
Dec 2001
$379.40M(+28.1%)
$112.41M(+19.2%)
$298.93M(+60.3%)
Sep 2001
-
$94.30M(+106.0%)
$186.52M(+102.2%)
Jun 2001
-
$45.77M(-1.5%)
$92.23M(+98.5%)
Mar 2001
-
$46.45M(+1.0%)
$46.45M(-63.7%)
Dec 2000
$296.22M(-221.2%)
-
-
Dec 1999
-$244.48M(-164.7%)
-
-
Dec 1998
$378.06M(+195.4%)
-
-
Dec 1997
$128.00M(+17.4%)
$46.00M(+58.6%)
$128.00M(+19.6%)
Sep 1997
-
$29.00M(+11.5%)
$107.00M(+1.9%)
Jun 1997
-
$26.00M(-3.7%)
$105.00M(-0.9%)
Mar 1997
-
$27.00M(+8.0%)
$106.00M(-2.8%)
Dec 1996
$109.00M(+34.6%)
$25.00M(-7.4%)
$109.00M(-3.5%)
Sep 1996
-
$27.00M(0.0%)
$113.00M(+8.7%)
Jun 1996
-
$27.00M(-10.0%)
$104.00M(+10.6%)
Mar 1996
-
$30.00M(+3.4%)
$94.00M(+16.0%)
Dec 1995
$81.00M(-75.6%)
$29.00M(+61.1%)
$81.00M(-74.8%)
Sep 1995
-
$18.00M(+5.9%)
$321.00M(+1.3%)
Jun 1995
-
$17.00M(0.0%)
$317.00M(-6.8%)
Mar 1995
-
$17.00M(-93.7%)
$340.00M(+1.2%)
Dec 1994
$332.00M(+514.8%)
$269.00M(+1821.4%)
$336.00M(+320.0%)
Sep 1994
-
$14.00M(-65.0%)
$80.00M(+1.3%)
Jun 1994
-
$40.00M(+207.7%)
$79.00M(+49.1%)
Mar 1994
-
$13.00M(0.0%)
$53.00M(-1.9%)
Dec 1993
$54.00M(-82.5%)
$13.00M(0.0%)
$54.00M(-53.4%)
Sep 1993
-
$13.00M(-7.1%)
$116.00M(-18.9%)
Jun 1993
-
$14.00M(0.0%)
$143.00M(-35.3%)
Mar 1993
-
$14.00M(-81.3%)
$221.00M(-25.1%)
Nov 1992
-
$75.00M(+87.5%)
$295.00M(-4.5%)
Aug 1992
$309.00M(-12.5%)
$40.00M(-56.5%)
$309.00M(+14.9%)
May 1992
-
$92.00M(+4.5%)
$269.00M(+52.0%)
Feb 1992
-
$88.00M(-1.1%)
$177.00M(+98.9%)
Nov 1991
-
$89.00M(+6.0%)
$89.00M(+6.0%)
Aug 1991
$353.00M(+3.2%)
-
-
Nov 1990
-
$84.00M
$84.00M
Aug 1990
$342.20M
-
-

FAQ

  • What is Humana annual EBITDA?
  • What is the all time high annual EBITDA for Humana?
  • What is Humana annual EBITDA year-on-year change?
  • What is Humana quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Humana?
  • What is Humana quarterly EBITDA year-on-year change?
  • What is Humana TTM EBITDA?
  • What is the all time high TTM EBITDA for Humana?
  • What is Humana TTM EBITDA year-on-year change?

What is Humana annual EBITDA?

The current annual EBITDA of HUM is $3.35B

What is the all time high annual EBITDA for Humana?

Humana all-time high annual EBITDA is $5.50B

What is Humana annual EBITDA year-on-year change?

Over the past year, HUM annual EBITDA has changed by -$1.44B (-30.13%)

What is Humana quarterly EBITDA?

The current quarterly EBITDA of HUM is $2.07B

What is the all time high quarterly EBITDA for Humana?

Humana all-time high quarterly EBITDA is $2.81B

What is Humana quarterly EBITDA year-on-year change?

Over the past year, HUM quarterly EBITDA has changed by +$651.00M (+46.01%)

What is Humana TTM EBITDA?

The current TTM EBITDA of HUM is $4.00B

What is the all time high TTM EBITDA for Humana?

Humana all-time high TTM EBITDA is $6.52B

What is Humana TTM EBITDA year-on-year change?

Over the past year, HUM TTM EBITDA has changed by -$263.00M (-6.17%)
On this page